Cargando…
Impact of Cell-Free Fetal DNA Screening on Patients’ Choice of Invasive Procedures after a Positive California Prenatal Screen Result
Until recently, maternal serum analyte levels paired with sonographic fetal nuchal translucency measurement was the most accurate prenatal screen available for Trisomies 18 and 21, (91% and 94% detection and false positive rates of 0.31% and 4.5% respectively). Women with positive California Prenata...
Autores principales: | Shah, Forum T., Steinhaus French, Kathryn, Osann, Kathryn E., Bocian, Maureen, Jones, Marilyn C., Korty, Lauren |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4449655/ https://www.ncbi.nlm.nih.gov/pubmed/26237481 http://dx.doi.org/10.3390/jcm3030849 |
Ejemplares similares
-
Just choice: a Danielsian analysis of the aims and scope of prenatal screening for fetal abnormalities
por: Stapleton, Greg, et al.
Publicado: (2019) -
Prenatal Screening, Reproductive Choice, and Public Health
por: Wilkinson, Stephen
Publicado: (2015) -
Patient-Centered Obstetric Care in the Age of Cell-Free Fetal DNA Prenatal Screening
por: Agatisa, Patricia K, et al.
Publicado: (2017) -
Overall evaluation of the clinical value of prenatal screening for fetal-free DNA in maternal blood
por: Yu, Bin, et al.
Publicado: (2017) -
Qualifying choice: ethical reflection on the scope of prenatal screening
por: Stapleton, Greg
Publicado: (2016)